Tempest Therapeutics (TPST) SEC Filings & 10K Form

$3.44
+0.02 (+0.58%)
(As of 04/24/2024 ET)

Recent Tempest Therapeutics SEC Filings

DateFilerForm TypeView
04/23/2024
3:04 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form DEFA14A
04/23/2024
3:06 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form ARS
03/19/2024
3:35 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
5:49 PM
EcoR1 Capital, LLC (Filed by)
Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Form SC 13G/A
02/14/2024
1:12 PM
Rock Springs Capital Management LP (Filed by)
Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Form SC 13G/A
02/08/2024
4:41 PM
Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
01/05/2024
3:38 PM
Maestas Nicholas (Reporting)
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:39 PM
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Trojanowski Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:40 PM
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Whiting Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:41 PM
Brady Stephen R (Reporting)
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
3:44 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form S-8 POS
11/17/2023
3:45 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form S-8 POS
11/17/2023
3:46 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form S-8 POS
11/17/2023
3:39 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/17/2023
3:43 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form S-8 POS
11/09/2023
4:28 PM
Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
11/08/2023
4:25 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
4:18 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:16 PM
Dubensky Thomas W. (Reporting)
Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2023
5:06 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
3:38 PM
Maestas Nicholas (Reporting)
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
3:39 PM
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Whiting Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
3:39 PM
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Trojanowski Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
3:41 PM
Brady Stephen R (Reporting)
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
5:06 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 424B5
10/11/2023
7:29 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-A12B
10/11/2023
7:13 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2023
3:16 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
3:19 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
3:46 PM
Simantov Ronit (Reporting)
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:48 PM
Pellizzari Christine A (Reporting)
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:50 PM
NICHOL GEOFFREY (Reporting)
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:53 PM
RAAB MICHAEL (Reporting)
Tempest Therapeutics, Inc. (Issuer)
Tempest Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:22 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2023
3:15 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form ARS
04/28/2023
7:30 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TPST) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners